TBK1 and amyotrophic lateral sclerosis: It is possible to combine various therapeutic approaches to modulate TBK1 activity in ALS, such as ATP-competitive inhibitors, allosteric modulators, drug repurposing, gene replacement, allele-specific silencing, and biomarker-driven stratification, which is increasingly an important element of translation [83,84,85] (Figure 3).